Clindamycin 4-Phosphate

Clindamycin 4-Phosphate Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Clindamycin (C580000) impurity.

Clindamycin 4-Phosphate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Clindamycin 4-Phosphate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14336	58
career henan chemical co	+86-0371-86658258 15093356674;	factory@coreychem.com	China	29826	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12382	58
Guangzhou Juntang Technology Co., Ltd	020-36607679 13502246435	sales@dmstandards.com	China	10951	58
Hubei Ruinuo Pharmaceutical Technology Co., Ltd	13165688766	3008058303@qq.com	China	5000	58
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15421	60
S.Z. PhyStandard Bio-Tech. Co., Ltd.	0755-83725681-603		China	4505	50
Beijing Comparison Pharmaceutical Technology Co., Ltd	010-52878169 15701683040	sales@bjcomparison.com	China	4713	58
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	17993	56
Shanghai Kewel Chemical Co., Ltd.	021-64609169 18901607656	greensnown@163.com	China	9911	50

54887-30-8()Verwandte Suche:

---

• Clindamycin 4-Phosphate
• ClindaMycin 4-Phosphate DISCONTINUED
• OZDNESASKLVYBG-TXGWZQRJSA-N
• (2R,3R,4R,5R,6R)-2-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate
• Clindamycin Impurity 13(Clindamycin Phosphate EP Impurity D)
• Clindamycin phosphate Impurity D(Clindamycin 4-Phosphatediscontinued)
• Clindamycin EP Impurity D
• Clindamycin Phosphate EP Impurity D/Clindamycin 4-Phosphate/methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl]amino]-4-O-phosphono-1-thio-L-threo-α-D-galacto-octopyranoside
• (2R,3R,4R,5R,6R)-2
• L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, 4-(dihydrogen phosphate), (2S-trans)- (9CI)
• (2R,3R,4R,5R,6R)-2-[(1S,2R)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-6-methylsulfanyloxan-3-yl] dihydrogen phosphate
• Clindamycin Phosphate Impurity D
• (2R,3R,4R,5R,6R)-2-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4- propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-6- (methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate formate
• Clindamycin Phosphas EP Impurity D
• methyl7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl]amino]-3-O-phosphono-1-thio-L-threo-α-d-galacto-octopyranoside(clindamycin3-phosphate)
• 2-(2-Chloro-1-(1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate (Clindamycin Phosphate Impurity)
• 54887-30-8
• Carbohydrates & Derivatives
• Heterocycles
• Impurities
• Intermediates & Fine Chemicals
• Pharmaceuticals
• Phosphorylating and Phosphitylating Agents